Related references
Note: Only part of the references are listed.Mildronate, the inhibitor of L-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation
Marina Makrecka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Targeting Carnitine Biosynthesis: Discovery of New Inhibitors against γ-Butyrobetaine Hydroxylase
Kaspars Tars et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of L-carnitine and to reduce myocardial infarct size
Edgars Liepinsh et al.
PHARMACOLOGICAL RESEARCH (2014)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: TRANSPORTERS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion
Edgars Liepinsh et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Troubleshooting digital macro photography for image acquisition and the analysis of biological samples
Edgars Liepinsh et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury
John R. Ussher et al.
CARDIOVASCULAR RESEARCH (2012)
The Cardioprotective Effect of Mildronate is Diminished After Co-Treatment With L-Carnitine
Janis Kuka et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion
Offir Ertracht et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation
Liyan Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats
Edgars Liepinsh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Mildronate treatment alters γ-butyrobetaine and L-carnitine concentrations in healthy volunteers
Edgars Liepinsh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Measuring long-chain acyl-coenzyme A concentrations and enrichment using liquid chromatography/tandem mass spectrometry with selected reaction monitoring
Agnieszka U. Blachnio-Zabielska et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis
Leah P. Shriver et al.
SCIENTIFIC REPORTS (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Modulation of myocardial metabolism: an emerging therapeutic principle
John D. Horowitz et al.
CURRENT OPINION IN CARDIOLOGY (2010)
The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats
Regula Schuerch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Electron Transport Chain-dependent and -independent Mechanisms of Mitochondrial H2O2 Emission during Long-chain Fatty Acid Oxidation
Erin L. Seifert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction
Iyyapu K. Mohan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats
Edgars Liepinsh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells
David Sebastian et al.
JOURNAL OF LIPID RESEARCH (2009)
Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Mildronate, a Regulator of Energy Metabolism, Reduces Atherosclerosis in apoE/LDLR-/- Mice
Reinis Vilskersts et al.
PHARMACOLOGY (2009)
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance
Muhammad A. Abdul-Ghani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Different effects of palmitoyl-L-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes
Hiromutsu Tominaga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Effect of inhibiting carnitine biosynthesis on male rat sexual performance
Maija Dambrova et al.
PHYSIOLOGY & BEHAVIOR (2008)
TNFα is required to confer protection in an in vivo model of classical ischaemic preconditioning
Graeme A. Deuchar et al.
LIFE SCIENCES (2007)
Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction
Edgars Liepinsh et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation
A Bentebibel et al.
BIOCHEMISTRY (2006)
Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium
SA Unger et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat
P Degrace et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation
JRB Dyck et al.
CIRCULATION RESEARCH (2004)
Mildronate: Cardioprotective action through carnitine-lowering effect
M Dambrova et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
PF Kantor et al.
CIRCULATION RESEARCH (2000)
Share Paper
